Prethi Sundaram-Mohip, DO
Dermatology · Delray Beach, FLNPI 1427223155
Payments from drug & device makers
Across 91 payments — averaging $24.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$666
- Sun Pharmaceutical Industries Inc.$335
- AbbVie$280
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$119
- Incyte Corporation$117
- Regeneron Healthcare Solutions, Inc.$107
- plus $602 from 13 others
What the payments were for
- Food & beverage$1,99490%
- Education$23210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 27 | $666 |
| Sun Pharmaceutical Industries Inc. | 9 | $335 |
| AbbVie | 12 | $280 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $119 |
| Incyte Corporation | 5 | $117 |
| Regeneron Healthcare Solutions, Inc. | 3 | $107 |
| VYNE Pharmaceuticals Inc. | 4 | $95 |
| Amgen | 3 | $89 |
| Pfizer | 3 | $73 |
| Novartis | 3 | $73 |
| Lilly USA, LLC | 4 | $70 |
| Johnson & Johnson | 3 | $55 |
| Biofrontera Inc. | 2 | $41 |
| Galderma Laboratories, L.p. | 2 | $38 |
| Boehringer Ingelheim | 1 | $25 |
| Almirall LLC | 1 | $18 |
| LEO Pharma Inc. | 1 | $14 |
| Organon | 1 | $8 |
| Mayne Pharma Commercial LLC | 1 | $3 |
How this compares
$2,226 in reported general payments places this provider in the 40th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 124 | $883 |
| Ketoconazole | 63 | $875 |
| Metronidazole | 17 | $797 |
| Gentamicin Sulfate | 17 | $625 |
| Nystatin | 62 | $594 |
| Doxycycline Hyclate | 22 | $510 |
| Clindamycin Phosphate | 18 | $468 |
| Clobetasol Propionate | 11 | $272 |
| Mupirocin | 38 | $237 |
| Cephalexin | 17 | $130 |
| Methylprednisolone | 12 | $85 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Delray Beach
- Brian FeinsteinDelray Beach$3.6M
- John StrasswimmerDelray Beach$1.4M
- Andrea ColtonDelray Beach$797K
- Brent SchillingerDelray Beach$606K
- Barry KuttnerDelray Beach$597K
- Michael SherlingLake Worth$78.9M
- Seth FormanTampa$28.2M
- Thomas TaylorTampa$13.6M
- Frank DonHallandale Beach$7.5M
- Francisco FloresMiramar$6.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.